Langer firm Taris Biomedical secures $18.3 million in Series B financing

April 19, 2011 | Analyst Insight

Taris Biomedical, a drug-device delivery company for treatment of bladder disease, recently secured $18.3 million in Series B equity financing. The funding round brought on a new investor, Third Rock Ventures, but...